SafeTraces
SafeTraces is a Pleasanton, California biotech company using DNA-based tags licensed from Lawrence Livermore National Laboratory.
About
SafeTraces is a Pleasanton, California biotech company using DNA-based tags licensed from Lawrence Livermore National Laboratory. It offers veriDART DNA-tagged aerosol tracers for airflow and air-cleaning validation, the PathogenSentinel pathogen biosensor and a cloud analytics platform for healthcare, schools, commercial real estate and biodefense; it originally applied DNA tags to food traceability.
Capital graph
Founders / team· 3
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- SafeTraces
SafeTraces is a Pleasanton, California biotech company using DNA-based tags licensed from Lawrence Livermore National Laboratory. It offers veriDART DNA-tagged aerosol tracers for airflow and air-cleaning validation, the PathogenSentinel pathogen biosensor and a cloud analytics platform for healthcare, schools, commercial real estate and biodefense; it originally applied DNA tags to food traceability.
$7M
$7M
United States
BusinessLatest roundTotal raisedDate- Fieldstone Bio
AI-based biosensor technology that detects environmental hazards using programmed microbes
Seed · $5M · 2025-05
$5M - Clair Health
Noninvasive continuous hormone-monitoring wearable and companion app for women, using machine learning to infer hormone levels from biosensor data
$12M
$12M - HyperSpectral
Rapid bacterial pathogen detection combining AI and spectroscopy
Series A · $16M · 2025-10
$16M
Europe
BusinessLatest roundTotal raisedDate- Silvia Bio
Biologics manufacturing process optimization: bioinformatics analysis + cell assay kits + licensable culture media additives
Seed · $4M · 2026-10
$4M - Dehaze
AI analysis of existing patient data to find missed diagnoses, flag inappropriate treatments and predict future health risks
Seed · $4M · 2026-05
$4M - Resurrect Bio
AI and protein interaction modeling to identify gene edits that restore crops' natural resistance to pathogens and pests
Series A · $10M · 2026-05
$10M
Other / unspecified
BusinessLatest roundTotal raisedDate- Cent
Annual preventive health check protocol for consumers: whole-body MRI, low-dose CT, DEXA, ECG/ultrasound and 100+ blood and urine biomarkers, with an in-house AI system synthesizing multimodal imaging and biomarker data into health scores and risk ratings; runs its own clinical prevention centers in Bengaluru, Mumbai and Delhi NCR, and works with Siemens Healthineers to shorten scan times.
$5M
$5M - Mediwhale
AI analysis of retinal images to predict cardiovascular, kidney and eye disease risk
Series A · $12M · 2024-09
$12M - Reliant AI
Uses generative AI to help biopharma companies organize and analyze data for clinical trials or scientific publications
Seed · $11M · 2024-08
$11M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Andreessen Horowitz
24 Life Sciences deals in the last 24 months · 22 in Silicon Valley
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.